Skip to main content
. 2020 Aug;13(2):130–141. doi: 10.2174/1874471013666200511000532

Fig. (6).

Fig. (6)

Percentage of injected activity per gram of tissue (%ID/g) ± SD of [212Pb]PbCl2, [212Pb]Pb-NG001 and [212Pb]Pb-PSMA-617 (top) and radium-224 (bottom) at 2 hours after intravenous injection of 224Ra-solution containing [212Pb]PbCl2, [212Pb]Pb-NG001 or [212Pb]Pb-PSMA-617 in athymic mice bearing human prostate C4-2 cancer xenografts (n=3-5 mice per group). (A higher resolution / colour version of this figure is available in the electronic copy of the article).